Pancreatic cancer is one of the most lethal malignancies and is associated with a poor
prognosis. Surgery is considered the only potential curative treatment for pancreatic cancer …

Pancreatic cancer is one of the most malignant tumours with a poor prognosis. In recent
years, the incidence of pancreatic cancer is on the rise. Traditional chemotherapy and …

The distinct biology of pancreatic cancer with aggressive and early invasive tumor cells, a
tumor promoting microenvironment, late diagnosis, and high therapy resistance poses major …

Pancreatic cancer is considered one of the most lethal malignances. It has been observed
that the five year survival rate is less than 5%. Early diagnosis, understanding the risk factors …

Pancreatic cancer is one of the most lethal solid organ tumors. Due to the rising incidence,
late diagnosis, and limited treatment options, it is expected to be the second leading cause …

Pancreatic cancer (PC) is the 5th leading cause of cancer related death in the developed
world with more than 260,000 deaths annually worldwide and with a dismal 5-year survival …

Pancreatic cancer is a disease with a high mortality rate and short survival, as a result of the
high incidence of metastatic disease at diagnosis, the fulminant clinical course and the lack …

Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to
become the second leading cause of cancer-related deaths in the next decade. Despite 5 …

Pancreatic cancer is the fourth leading cause of cancer-related death in the United States,
with increasing incidence. The mortality rate of pancreatic cancer is rising rapidly, and is …

Patients with pancreatic cancer have a poor prognosis with a median survival of 4-6 mo and
a 5-year survival of less than 5%. Despite therapy with gemcitabine, patient survival does …